KR101955735B1 - 신규한 골드-백금계 복금속 나노결정 현탁액, 그의 전기화학 제조 방법 및 그의 용도 - Google Patents

신규한 골드-백금계 복금속 나노결정 현탁액, 그의 전기화학 제조 방법 및 그의 용도 Download PDF

Info

Publication number
KR101955735B1
KR101955735B1 KR1020137028744A KR20137028744A KR101955735B1 KR 101955735 B1 KR101955735 B1 KR 101955735B1 KR 1020137028744 A KR1020137028744 A KR 1020137028744A KR 20137028744 A KR20137028744 A KR 20137028744A KR 101955735 B1 KR101955735 B1 KR 101955735B1
Authority
KR
South Korea
Prior art keywords
suspension
platinum
water
gold
electrode
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
KR1020137028744A
Other languages
English (en)
Korean (ko)
Other versions
KR20140020310A (ko
Inventor
아담 알. 도르프만
데이비드 에이스. 브라이스
맥스웰 에이. 그레이스
디. 카일 피어스
미카힐 메르즐라코브
마크 지. 모르텐슨
Original Assignee
클레네 나노메디슨, 인크.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 클레네 나노메디슨, 인크. filed Critical 클레네 나노메디슨, 인크.
Publication of KR20140020310A publication Critical patent/KR20140020310A/ko
Application granted granted Critical
Publication of KR101955735B1 publication Critical patent/KR101955735B1/ko
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/242—Gold; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/243—Platinum; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/143—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1611—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82B—NANOSTRUCTURES FORMED BY MANIPULATION OF INDIVIDUAL ATOMS, MOLECULES, OR LIMITED COLLECTIONS OF ATOMS OR MOLECULES AS DISCRETE UNITS; MANUFACTURE OR TREATMENT THEREOF
    • B82B1/00—Nanostructures formed by manipulation of individual atoms or molecules, or limited collections of atoms or molecules as discrete units
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82B—NANOSTRUCTURES FORMED BY MANIPULATION OF INDIVIDUAL ATOMS, MOLECULES, OR LIMITED COLLECTIONS OF ATOMS OR MOLECULES AS DISCRETE UNITS; MANUFACTURE OR TREATMENT THEREOF
    • B82B3/00—Manufacture or treatment of nanostructures by manipulation of individual atoms or molecules, or limited collections of atoms or molecules as discrete units
    • B82B3/0009—Forming specific nanostructures
    • C—CHEMISTRY; METALLURGY
    • C22—METALLURGY; FERROUS OR NON-FERROUS ALLOYS; TREATMENT OF ALLOYS OR NON-FERROUS METALS
    • C22C—ALLOYS
    • C22C30/00—Alloys containing less than 50% by weight of each constituent
    • C—CHEMISTRY; METALLURGY
    • C22—METALLURGY; FERROUS OR NON-FERROUS ALLOYS; TREATMENT OF ALLOYS OR NON-FERROUS METALS
    • C22C—ALLOYS
    • C22C5/00—Alloys based on noble metals
    • C22C5/02—Alloys based on gold
    • C—CHEMISTRY; METALLURGY
    • C22—METALLURGY; FERROUS OR NON-FERROUS ALLOYS; TREATMENT OF ALLOYS OR NON-FERROUS METALS
    • C22C—ALLOYS
    • C22C5/00—Alloys based on noble metals
    • C22C5/04—Alloys based on a platinum group metal
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Metallurgy (AREA)
  • Materials Engineering (AREA)
  • Mechanical Engineering (AREA)
  • Nanotechnology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medical Informatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Manufacturing & Machinery (AREA)
  • Molecular Biology (AREA)
  • Manufacture Of Metal Powder And Suspensions Thereof (AREA)
  • Powder Metallurgy (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Catalysts (AREA)
KR1020137028744A 2011-03-30 2012-03-30 신규한 골드-백금계 복금속 나노결정 현탁액, 그의 전기화학 제조 방법 및 그의 용도 Active KR101955735B1 (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161469525P 2011-03-30 2011-03-30
US61/469,525 2011-03-30
PCT/US2012/031654 WO2012135743A2 (en) 2011-03-30 2012-03-30 Novel gold-platinum based bi-metallic nanocrystal suspensions, electrochemical manufacturing processes therefor and uses for the same

Related Child Applications (1)

Application Number Title Priority Date Filing Date
KR1020197006058A Division KR102103534B1 (ko) 2011-03-30 2012-03-30 신규한 골드-백금계 복금속 나노결정 현탁액, 그의 전기화학 제조 방법 및 그의 용도

Publications (2)

Publication Number Publication Date
KR20140020310A KR20140020310A (ko) 2014-02-18
KR101955735B1 true KR101955735B1 (ko) 2019-03-07

Family

ID=46932416

Family Applications (2)

Application Number Title Priority Date Filing Date
KR1020197006058A Active KR102103534B1 (ko) 2011-03-30 2012-03-30 신규한 골드-백금계 복금속 나노결정 현탁액, 그의 전기화학 제조 방법 및 그의 용도
KR1020137028744A Active KR101955735B1 (ko) 2011-03-30 2012-03-30 신규한 골드-백금계 복금속 나노결정 현탁액, 그의 전기화학 제조 방법 및 그의 용도

Family Applications Before (1)

Application Number Title Priority Date Filing Date
KR1020197006058A Active KR102103534B1 (ko) 2011-03-30 2012-03-30 신규한 골드-백금계 복금속 나노결정 현탁액, 그의 전기화학 제조 방법 및 그의 용도

Country Status (15)

Country Link
US (3) US9387225B2 (enExample)
EP (1) EP2691082B1 (enExample)
JP (1) JP6121985B2 (enExample)
KR (2) KR102103534B1 (enExample)
CN (1) CN103764123B (enExample)
BR (1) BR112013025112A2 (enExample)
CA (1) CA2829095C (enExample)
DK (1) DK2691082T3 (enExample)
ES (1) ES2564672T3 (enExample)
IL (1) IL228356A (enExample)
MX (1) MX337439B (enExample)
PH (1) PH12013501954A1 (enExample)
RU (1) RU2617055C2 (enExample)
SG (1) SG193439A1 (enExample)
WO (1) WO2012135743A2 (enExample)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI2178796T1 (sl) * 2007-07-11 2021-04-30 Clene Nanomedicine, Inc. Kontinuiran postopek za obdelavo tekočin in proizvodnjo določenih sestavin
EP2735389A1 (de) * 2012-11-23 2014-05-28 Universität Duisburg-Essen Verfahren zur Herstellung reiner, insbesondere kohlenstofffreier Nanopartikel
JP5891320B1 (ja) * 2015-02-12 2016-03-22 秋田県 ゼータ電位制御法を用いた処理方法
CN106680450B (zh) * 2017-03-23 2023-04-25 江西省农业科学院农业经济与信息研究所 水质监测装置及方法
US11674234B1 (en) * 2020-09-30 2023-06-13 National Technology & Engineering Solutions Of Sandia, Llc Electrodeposited platinum-gold alloy
CN112683710B (zh) * 2020-12-02 2024-04-16 大连理工大学 一种氯离子侵蚀下钢筋混凝土桥板加速腐蚀的试验装置
CN112935273A (zh) * 2021-01-26 2021-06-11 哈尔滨理工大学 一种室温制备CuPt合金纳米颗粒的方法
JP2022131579A (ja) 2021-02-26 2022-09-07 キオクシア株式会社 分析装置および分析方法
CN113500199B (zh) * 2021-06-10 2022-11-08 浙江大学 一种基于金铂双金属活性氧自生成纳米材料的制备方法及其产品和应用
CN113777034B (zh) * 2021-08-20 2024-04-19 嘉兴学院 金纳米双锥阵列基底及其制备方法和应用
CN114470201B (zh) * 2021-12-24 2024-03-19 上海市儿童医院 一种装载kcna5抗体的金铂纳米颗粒及其制备方法和应用
CN120504491B (zh) * 2025-07-21 2025-09-16 景德镇学院 一种稳定陶瓷釉料烧制发色的添加剂及其方法

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002212102A (ja) 2001-01-23 2002-07-31 Ainobekkusu Kk 電気化学的生理活性微粒子
JP2003522149A (ja) 2000-02-08 2003-07-22 ライスユニバーシティ 治療法および診断法において使用される光学活性なナノ粒子
WO2010083040A1 (en) * 2009-01-15 2010-07-22 Gr Intellectual Reserve, Llc Continuous semicontinuous and batch methods for treating liquids and manufacturing certain constituents (e.g., nanoparticles) in liquids, apparatuses and nanoparticles and nanoparticle/liquid solution(s) and colloids resulting therefrom

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6989157B2 (en) * 2000-07-27 2006-01-24 Nucryst Pharmaceuticals Corp. Dry powders of metal-containing compounds
US7001617B2 (en) * 2001-04-23 2006-02-21 Nueryst Pharmaceuticals Corp. Method of induction of apoptosis and inhibition of matrix metalloproteinases using antimicrobial metals
EP1383521A2 (en) * 2001-04-23 2004-01-28 Nucryst Pharmaceuticals Corp. Medicament containing a metal such as silver, gold, platinum or palladium as an antimicrobial agent and their use to induce apoptosis in cancerous tissue
US20080190770A1 (en) * 2004-04-26 2008-08-14 Cap Technologies, Llc Treatment of Fluids and/or Sludge with Electro Plasma
JPWO2006101106A1 (ja) * 2005-03-23 2008-09-04 アプト株式会社 貴金属ナノコロイド溶液
CA2639872A1 (en) * 2006-01-03 2007-07-12 Gr Intellectual Reserve, Llc Methods and apparatuses for making liquids more reactive
KR100857389B1 (ko) * 2006-06-30 2008-09-11 (주)아모레퍼시픽 Ａｐ-ｇｒｒ 펩티드 또는 ａｐ-ｇｒｒ 펩티드를 포함하는펩티드사슬 및 이를 포함하는 약물전달담체
TW200819540A (en) 2006-07-11 2008-05-01 Genelux Corp Methods and compositions for detection of microorganisms and cells and treatment of diseases and disorders
SI2178796T1 (sl) 2007-07-11 2021-04-30 Clene Nanomedicine, Inc. Kontinuiran postopek za obdelavo tekočin in proizvodnjo določenih sestavin
CA2700378A1 (en) * 2007-09-21 2009-03-29 Cytimmune Sciences, Inc. Nanotherapeutic colloidal metal compositions and methods
EP2451284B8 (en) * 2009-07-08 2017-05-24 Clene Nanomedicine, Inc. Novel gold-based nanocrystals for medical treatments and electrochemical manufacturing processes therefor
KR101090431B1 (ko) * 2009-08-19 2011-12-07 삼성전기주식회사 금속 씨앗을 이용한 금속 나노입자의 제조 방법 및 금속 씨앗을 함유하는 금속 나노입자

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003522149A (ja) 2000-02-08 2003-07-22 ライスユニバーシティ 治療法および診断法において使用される光学活性なナノ粒子
JP2002212102A (ja) 2001-01-23 2002-07-31 Ainobekkusu Kk 電気化学的生理活性微粒子
WO2010083040A1 (en) * 2009-01-15 2010-07-22 Gr Intellectual Reserve, Llc Continuous semicontinuous and batch methods for treating liquids and manufacturing certain constituents (e.g., nanoparticles) in liquids, apparatuses and nanoparticles and nanoparticle/liquid solution(s) and colloids resulting therefrom

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
J. Phys. Chem. C 2007, 111, 6183-6188

Also Published As

Publication number Publication date
EP2691082A4 (en) 2015-06-24
WO2012135743A2 (en) 2012-10-04
SG193439A1 (en) 2013-10-30
IL228356A0 (en) 2013-12-31
KR20190027933A (ko) 2019-03-15
RU2617055C2 (ru) 2017-04-19
MX337439B (es) 2016-03-03
CA2829095A1 (en) 2012-10-04
EP2691082B1 (en) 2016-01-13
JP6121985B2 (ja) 2017-04-26
JP2014518847A (ja) 2014-08-07
IL228356A (en) 2017-04-30
EP2691082A2 (en) 2014-02-05
KR102103534B1 (ko) 2020-04-23
ES2564672T3 (es) 2016-03-28
NZ617018A (en) 2015-10-30
US20230172975A1 (en) 2023-06-08
CA2829095C (en) 2019-08-27
BR112013025112A2 (pt) 2020-09-29
RU2013148011A (ru) 2015-05-10
WO2012135743A3 (en) 2014-05-01
CN103764123B (zh) 2018-03-13
AU2012236213A1 (en) 2013-11-14
PH12013501954A1 (en) 2013-11-25
CN103764123A (zh) 2014-04-30
US9387225B2 (en) 2016-07-12
DK2691082T3 (en) 2016-02-29
US20160317578A1 (en) 2016-11-03
KR20140020310A (ko) 2014-02-18
US20140294963A1 (en) 2014-10-02
MX2013011245A (es) 2013-10-17
AU2012236213A2 (en) 2014-01-23

Similar Documents

Publication Publication Date Title
KR101955735B1 (ko) 신규한 골드-백금계 복금속 나노결정 현탁액, 그의 전기화학 제조 방법 및 그의 용도
JP7014851B2 (ja) 医学的治療のための新規の金系ナノ結晶、及び該金系ナノ結晶のための電気化学的製造方法
AU2018203373B2 (en) Novel gold-based nanocrystals
AU2012236213B2 (en) Novel gold-platinum based bi-metallic nanocrystal suspensions, electrochemical manufacturing processes therefor and uses for the same
NZ617018B2 (en) Novel gold-platinum based bi-metallic nanocrystal suspensions, electrochemical manufacturing processes therefor and uses for the same

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20131030

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
N231 Notification of change of applicant
PN2301 Change of applicant

Patent event date: 20170201

Comment text: Notification of Change of Applicant

Patent event code: PN23011R01D

PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 20170329

Comment text: Request for Examination of Application

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20180411

Patent event code: PE09021S01D

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

Patent event code: PE07011S01D

Comment text: Decision to Grant Registration

Patent event date: 20181128

PA0104 Divisional application for international application

Comment text: Divisional Application for International Patent

Patent event code: PA01041R01D

Patent event date: 20190227

PR0701 Registration of establishment

Comment text: Registration of Establishment

Patent event date: 20190228

Patent event code: PR07011E01D

PR1002 Payment of registration fee

Payment date: 20190228

End annual number: 3

Start annual number: 1

PG1601 Publication of registration
PR1001 Payment of annual fee

Payment date: 20220217

Start annual number: 4

End annual number: 4